文摘
NAT2 (arylamine N-acetyltransferase 2) polymorphism, being a key determinant of individual variations in acetylation capacity, is suspected to modify the risk of carcinogen-related malignancies. As tobacco smoke and other inhaled hazards contain a variety of NAT2 substrates, the relationship between NAT2 phenotype and lung cancer (LC) risk has been a subject of intensive research, however different case–control studies produced controversial data. In the present report, we employed a novel ‘comparison of extremes’ approach, i.e. we compared the distribution of NAT2 genotypes in lung cancer patients (LC, n